Side-by-side lacrimal intubation threader and method

ABSTRACT

A device to facilitate insertion or threading of a flexible silicone intubation stent into the lacrimal drainage system of a patient. The device has an oblong hollow semi-rigid probe having the flexible stent releasably secured to its blunted distal end. The probe and stent are oriented in a side-by-side configuration and inserted endwise through the punctal opening, down through the nasolacrimal duct and into the nasal cavity. The flexible stent is detached from the distal end of the probe, and the probe withdrawn, leaving the stent in place. The flexible stent can be temporarily secured to the distal end of the probe through a number of means. One preferred way is to friction fit a resilient distal aperture of the stent upon the distal end of the probe and occlude the probe&#39;s distal opening. The stent is detached by injecting a pressurized fluid through the channel of the probe thereby forcing the distal end of the stent to pop off. The proximal extremity of the stent is secured in the patient by an integrated or separate punctal anchor.

FIELD OF THE INVENTION

The present invention relates to devices used for normalizing the flowof fluid in tubular organs of human bodies that have been damaged by adisease or an accident. More specifically, the invention relates totreating punctal, canalicular and nasolacrimal duct damage, stenosis orobstruction.

BACKGROUND

The orbital portion of the lacrimal gland is located in thesuperotemporal orbit and the palpebral portion of the lacrimal gland islocated on the posterior surface of the superotemporal upper lid. Thelacrimal gland produces the aqueous portion of the tear film. Ductulesfrom the orbital portion of the lacrimal gland pass through the adjacentpalpebral lacrimal gland to empty in the superior conjunctivalcul-de-sac. Smaller accessory lacrimal glands in the upper and lowerlids also contribute to tear production. The tears bathe the surface ofthe eye and then drain into the nose via the lacrimal drainage system.

Referring now to FIGS. 1 and 2, the lacrimal drainage system comprises apair of small openings, namely the superior punctum 2 and inferiorpunctum 3, are located on the medial upper and lower lids of the eye 1.Tears flow into these puncta which lead to two small diameter delicatetubes, namely, the superior canaliculus 4 and the inferior canaliculus5. The canaliculi join together as a short common canaliculus 6 thatenters into the larger lacrimal sac 7. The tears then flow from thelacrimal sac down the nasolacrimal duct 8 and out an opening 9 whichempties into the nose on the lateral nasal wall 10 and on to the nasalfloor 11 beneath the inferior turbinate 12. This space beneath theinferior turbinate is called the inferior meatus 13 of the nasal cavity.

The canaliculi can become obstructed or stenotic on a congenital basis,or acquired as a result of some trauma such as lacerations,inflammation, side effects of chemotherapy, such as taxotere orfive-fluorouracil—which may also affect the nasolacrimal duct—or theobstruction can be idiopathic. Once obstructed, tears can no longerdrain from the surface of the eye through the lacrimal drainage systeminto the nose. As a result tears well up in the eye, and run down theface. Excess tears blur the vision and the patient has to constantly dabthe eye.

The nasolacrimal duct can be obstructed on a congenital basis, occurringin about 2% to 6% of newborns, or acquired as a result of some trauma,sarcoidosis or other diseases, but most commonly is idiopathic. When thenasolacrimal duct is obstructed, tears stagnate in the lacrimal sacwhere bacteria multiply leading to infection. The result is a painfulenlargement of the lacrimal sac swollen with pus, and a discharge overthe eye.

A congenital nasolacrimal duct obstruction often resolves spontaneously,or with the use of antibiotic drops and massage of the lacrimal sac.However, a significant number of patients require surgical treatment.

Canalicular obstruction or stenosis, and nasolacrimal duct obstructionsare often treated by forming a passageway through the obstruction orstenotic tissue using a surgical probe which is a small diameter,blunt-ended rod made of solid steel, bronze, silver or other metal. Aflattened area in the center of the probe facilitates its manipulation.

The passageway through the nasolacrimal duct can be further dilatedusing a balloon catheter through dacryocystoplasty (DCP). Often thetreatment of nasolacrimal duct obstruction in adults involves thecreation of a new passage from the lacrimal sac directly into the nasalcavity bypassing the nasolacrimal duct according to a procedure calleddacrocystorhinostomy (DCR). Both procedures are disclosed in my U.S.Pat. No. 5,169,386 incorporated herein by this reference.

Intubation or stenting of the lacrimal system is often performed afterlacrimal surgery or as a primary treatment for nasolacrimal ductobstruction, canalicular stenosis, or canalicular laceration, in orderto keep the lacrimal drainage passageway open and prevent scars frompermanently clogging the canaliculi or nasolacrimal duct.

In this specification the term “intubation” is meant to include theinsertion of both tubular and non-tubular oblong flexible devices intothe lacrimal drainage system in order to keep the passageway openregardless of whether tears flow through a tubular device or around anon-tubular device. Since tears typically flow around the device whetherit is tubular or not, the term “stent” in this specification is used tocollectively refer to a tubular or non-tubular device remaining insertedin the lacrimal drainage system after an intubation process has beenperformed.

In cases of canalicular or nasolacrimal duct obstruction fromchemotherapy, intubation is performed as quickly as possible to preventcomplete, irreversible closure. Intubation typically involves placementof a flexible silicone tube looped through both canaliculi where bothends extend down the nasolacrimal duct and into the nose. Suchintubation is described in Martinez, U.S. Pat. No. 4,305,395, andCrawford et al., U.S. Pat. No. 4,380,239, both of which are incorporatedherein by this reference.

A number of types of intubation devices are available. The most commontype is a silicone tube having a metal probe attached on each end as inCrawford et al. cited above. A probe on one end is pushed through one ofthe punctum, its canaliculus, the lacrimal sac, and down thenasolacrimal duct into the nose. The probe is grasped in the nose by thesurgeon and pulled out the naris. The tube follows the probe. The probeon the other end of the tube is pushed through the second punctum, itscanaliculus, the lacrimal sac, and down the nasolacrimal duct into thenose, grasped by the surgeon, and pulled out the naris bringing theother end of the tube with it. The probes are removed and the two endsof the tube are tied together and left hanging in the nose. The tube isremoved several months later by pulling it up the lacrimal system,cutting it, and removing it through one of the puncta.

The above process presents several difficulties. First, the nasalopening to the nasolacrimal duct is extremely difficult to visualizeduring surgery or examination, and very difficult to access with aninstrument, making the grasping of the probe difficult. Rigid andflexible endoscopes usually cannot fit between the inferior turbinateand the lateral nasal wall. Direct visualization using a nasal speculumand a headlight is usually not possible. Placing an instrument near thenasolacrimal duct opening through the nose can be very difficult. Aprobe or tube sticking out of the nasolacrimal duct opening in the nosewill often be buried in the surrounding soft tissue of the nasal flooror lateral wall. Further, there is often edema of the inferior turbinateand nasal mucosa, and sometimes bleeding which make it more difficult tolocate, access, grasp, and retrieve the probe, tube, suture or otheritem coming out of the nasolacrimal duct opening. It is often difficultif not impossible to position a suction catheter in the inferior meatusin order to remove blood around the nasolacrimal duct opening.

One way of trying to confirm without visualization whether the probe,tube or other item has penetrated into the nose is by touch. The surgeonwill typically introduce a metal instrument through the external narisinto the nose and try blindly to touch the tip of the item sticking outof the nasolacrimal duct opening until a contact between the two isfelt. Detecting contact takes quite a bit of skill and experience.Often, if no contact is felt, the surgeon may remove the item andreinsert it, then try again to confirm penetration. These repeatedprocedures can cause multiple traumas to the lacrimal drainage system.

Another commonly used intubation device is the MINI-MONOKA deviceavailable from FCI Ophthalmics Inc. of Marshfield Hills, Mass.(hereinafter “FCI”). This device consists of a short silicone tube whichis generally not long enough to extend into the nasolacrimal duct. Theproximal end of the tube is formed into a punctal plug to anchor it in apunctum. The tube is threaded through a punctum and canaliculus into thelacrimal sac, and can be used to stent the canaliculus but typically notthe nasolacrimal duct.

Another type of intubation device is the MONO-CRAWFORD device availablefrom FCI which is similar to the MINI-MONOKA device but provides alonger flexible stent. It also has a punctal plug at its proximal end.The distal end must be threaded through the lacrimal system from the eyeside but is too flexible to be pushed on its own through the system.

The RITLENG probe, also available from FCI, has been designed to helpthis problem. It is a hollow metal guide tube with a slit-like openingalong its entire length which is placed through the punctum,canaliculus, lacrimal sac, and down the nasolacrimal duct into the nose.A separate polyethylene tube that is attached to a flexible siliconetube having a punctal plug formed on its proximal end is threadedthrough the guide into the nose. The polyethylene tube is located andgrasped in the nose by the surgeon and pulled out the naris. The guideis then withdrawn out the punctum. The silicone tube passes through theslit so that the guide can be removed. The plug on the proximal end ofthe silicone tube is then seated in the punctum. The distal end of thesilicone tube is then cut just inside the external naris. Therefore, theRITLENG tube must be retrieved and pulled out the nose. This can bedifficult or impossible in some cases as detailed above.

Both the MINI-MONOKA and RITLENG devices use punctum plugs integrallyformed onto the proximal ends of flexible tubes. Therefore, the lengthof the tube can only be altered during surgery by cutting the distalend. The RITLENG and MONO-CRAWFORD tubes must be retrieved in the noseand brought out the nose to achieve this. The MINI-MONOKA tube is tooshort to have its length altered in vivo.

My U.S. patent application Publication No. 2007/0276314 incorporatedherein by this reference describes a silicone tube with a balloon on theend. It extends from the punctum and canaliculus into the lacrimal sac.A balloon on the end of the tube in the lacrimal sac is then inflated tokeep the tube in position. The tube does not extend into thenasolacrimal duct.

The FCI company has a plug that is placed in the punctum in order toobstruct the punctum and prevent tear drainage through the lacrimalsystem into the nose. This is used for patients with dry eye syndrome tokeep more tears in the tear film over the eye. The FCI plug has a lumenwith a proximal opening and a distal closed end. A metal probe at theend of an inserter stretches the tube along its longitudinal axis toreduce the diameter during insertion. When the plug is in place, theinserter is withdrawn and the plug contracts along its longitudinal axisand thus increases radially so that it will be snug in the punctum andnot fall out. The lumen does not expand. The device is not expandedradially by the inserter, but rather is expanded longitudinally whichdecreases its outside and inside diameter.

I show in International Publication No. WO 2007/139919 a lacrimal stentthat uses a soft tube, ideally silicone, that has a higher durometerreinforcer tube within the closed distal end. The silicone stent can beplaced in the lacrimal system through the punctum, canaliculus, commoncanaliculus, lacrimal sac, and nasolacrimal duct into the nose. Thesilicone tube and reinforcer have holes in the sidewalls in the distalend. A hollow irrigating probe having holes in the sidewalls is used topush the silicone tube into the lacrimal system and the distal end intothe nose. The irrigating probe allows fluorescein stained fluid to beirrigated through the tube and recovered in the nose to confirm that thesilicone tube has penetrated all obstructions and reached the nasalcavity. The reinforcer resists the probe puncturing the distal end ofthe silicone tube. The silicone tube does not need to be retrieved inthe nose.

There are however, certain problems that have been encountered. If thereis a very tight nasolacrimal duct or canaliculus, then the probe maystill puncture through the end of the silicone tube and reinforcer orotherwise rupture the tube. In this event it is impossible to emplacethe silicone tube in the lacrimal system.

Another problem is that the distance from the punctum through thelacrimal system to the nasal floor is quite variable between and withinage groups, and it is often difficult to predict the proper length ofthe stent to be used. Furthermore, the angle at which the silicone tubeand enclosed probe exit the nasolacrimal duct in the nose is differentamong patients. The angle of exit determines where the probe and tubehit the nasal floor. This is because the nasal floor is concave upwardwhere it comes off the lateral nasal wall. The point at which the probeand tube hit the nasal floor is a factor in determining the length ofsilicone tube needed. Silicone tubes of many different lengths must beavailable for the surgeons's use for these reasons.

The instant invention results from attempts to avoid the aforesaidproblems and provide more efficient, simpler and safer devices andprocedures in the treatment of nasolacrimal duct obstructions.

SUMMARY

The instant embodiments provide devices and method to better treatobstructions in the nasolacrimal system.

In some embodiments there is provided a method for placing a stent in apatient's nasolacrimal duct which comprises the steps of: selecting anelongated semirigid tubular probe and an elongated flexible stent;wherein said probe has a proximal end and a distal end; wherein saidstent has a proximal extremity and a distal extremity; wherein saiddistal extremity is detachably secured to said distal end; and, whereinsaid probe and said stent are oriented in a side-by-side configuration;pushing said distal end and said distal extremity through a patient'spunctum, canaliculus, lacrimal sac, nasolacrimal duct and into the nasalcavity; detaching said distal extremity from said distal end while saiddistal end is located in said cavity; proximally withdrawing said probewhile leaving said distal extremity in said cavity; and, placing apunctal anchor associated with said proximal extremity within saidpatient's punctum.

In some embodiments the method further comprises: said probe having aninternal channel, and a first opening to said channel near said proximalend; and a second opening to said channel near said distal end; and,wherein said stent occludes said second opening of said channel.

In some embodiments the second opening comprises an axial hole extendingthrough an endwall of said probe to said channel.

In some embodiments the second opening comprises at least one radialhole extending through a sidewall of said probe to said channel.

In some embodiments the step of selecting an elongated flexible stentfurther comprises: choosing said stent to be tubular; and, said distalextremity is open, and shaped and dimensioned to snugly fit over saiddistal end of said probe.

In some embodiments the step of detaching comprises: injecting a fluidinto said channel at a pressure sufficient to overcome a forcedetachably securing said distal extremity to said distal end.

In some embodiments the step of detaching comprises: inserting a rodinto said channel and contacting said distal extremity at a pressuresufficient to overcome a force detachably securing said distal extremityto said distal end.

In some embodiments the step of selecting comprises: determining a givenlength for said stent, wherein said determining comprises measuring adistance from said punctum to said nasal cavity; wherein said measuringcomprises: inserting a graduated probe through said punctum to saidnasal cavity; confirming a distal end of said graduated probe is locatedin said nasal cavity, and, identifying a graduation mark on saidgraduated probe closest to the punctal opening.

In some embodiments the method further comprises: stiffening said probeprior to said pushing; wherein said stiffening comprises: engaging saidchannel with an oblong rod having a first flexural rigidity which ismore rigid than a second flexural rigidity of said stent

In some embodiments the step of selecting of said probe comprises:choosing said probe to have at least one radial hole near said distalend of said probe and wherein said distal extremity engages said hole.

In some embodiments the step of detaching comprises pushing a styletinto said channel to cut said stent.

In some embodiments the method is practiced in absence of retrieving aportion of said stent out the naris.

In some embodiments the method is practiced in absence of visualizingsaid stent within said nasal cavity.

In some embodiments the method is practiced in absence of shorteningsaid stent in vivo.

In some embodiments the step of placing a punctal anchor occurs duringsaid pushing step.

In some embodiments the method further comprises: confirming that thedistal end is located in said nasal cavity; wherein said confirmingcomprises: injecting a tracing fluid through the probe; and recoveringtraces of said fluid in said nasal cavity.

In some embodiments the method further comprises injecting medicationinto said system through said probe.

In some embodiments there is provided a method for stenting a passagewayformed by dacryocystorhinostomy (“DCR”) which comprises the steps of:selecting an elongated tubular probe and an elongated flexible stent;wherein said probe has an open proximal end and an open distal end, anddefines an internal channel; and, wherein said stent has a proximalextremity and a distal extremity; and, wherein said distal extremity isdetachably secured to said distal end; pushing said probe carrying saidstent through said passageway and into the nasal cavity; confirming thatthe distal end of said probe is located in said nasal cavity; detachingsaid distal extemity from said distal end; proximally withdrawing saidprobe while leaving said stent in place; and, placing a punctal anchorassociated with a proximal extremity of said stent within said patient'spunctum.

In some embodiments there is provided a multi-functional surgical toolfor the treatment of nasolacrimal obstruction, stenosis or damage whichcomprises: a first elongated semirigid tubular probe having proximal anddistal ends; an elongated stent having proximal and distal extremities;wherein said distal extremity is releasably secured to said distal end;wherein said probe and said stent are oriented in a side-by-sideconfiguration; a punctal anchor associated with said proximal extremityof said stent; and, wherein said anchor is sized and shaped tointimately and oversizedly engage said punctum.

In some embodiments the probe is shaped and dimensioned to define aninternal channel; said probe has a first opening to said channel nearsaid proximal end; and a second opening to said channel near said distalend; and, said stent occludes said second opening of said channel.

In some embodiments the second opening comprises an axial hole.

In some embodiments the second opening comprises a radial hole.

In some embodiments the second opening comprises a pair of radial holesextending through a sidewall of said probe to said channel.

In some embodiments the stent has a distal aperture shaped anddimensioned to snugly and releasably engaged by said distal end to forma friction fit.

In some embodiments the probe has a distal opening shaped anddimensioned to snugly and releasably engaged by said distal extremity toform a friction fit.

In some embodiments the tool further comprises a first connector at aproximal end of said probe adapted to releasably connect to apressurized fluid source.

In some embodiments the source emits an amount of fluid at a pressuresufficient to overcome a static friction bond between said stent andsaid probe.

In some embodiments the tool further comprises a first rod diametricallysized to engage said channel of said probe.

In some embodiments the rod dimensioned to contact a portion of saidstent occluding said second opening.

In some embodiments the rod has distal cutting surface oriented to cutsaid stent through axial movement of said rod with respect to saidprobe.

In some embodiments of the tool: said probe has a first length; saidstent has a second length shorter than said first length; and, whereinsaid second length is between about 10 millimeters and about 100millimeters.

In some embodiments the probe has a maximum cross-sectional dimension ofbetween about 0.014 inch and about 0.060 inch.

In some embodiments the probe further comprises graduation marking on anouter surface portion located at a range of distances from said distalend corresponding to a common range of anatomical distances between apunctum and a nasal floor.

In some embodiments the probe has a first flexural rigidity allowing itto be introduced into a patient's nasolacrimal duct through one of saidpatient's canaliculi by pushing on portions of said probe locatedproximal to said one of said patient's canaliculi; and, said stenthaving a second flexural rigidity less rigid than said first rigidity.

In some embodiments the anchor has radial disuniformity shaped anddimensioned to rest against a medial sidewall of said probe, therebyminimizing a lateral dimension of the probe and stent oriented in saidside-by-side configuration.

In some embodiments there is provided a multi-functional surgical toolfor the treatment of nasolacrimal obstruction, stenosis or damage whichcomprises: a first elongated semirigid tubular probe having proximal anddistal ends, and defining an internal channel; said probe being sizedand having a first flexural rigidity to be introduced into a patient'snasolacrimal duct through one of said patient's canaliculi by pushing onportions of said probe located proximal to said one of said patient'scanaliculi; an elongated stent having proximal and distal extremities;said stent having a second flexural rigidity; wherein said secondrigidity is less rigid than said first rigidity; means for detachablysecuring said distal extemity to said distal end; and, an anchor sizedto intimately and oversizedly engage said punctum.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a cross-sectional frontal illustration of the lacrimaldrainage system of a human patient.

FIG. 2 is a partial, cross-sectional side illustration of the system ofFIG. 1.

FIG. 3 is a cross-sectional side view illustration of a combinedprobe/stent insertion structure.

FIG. 4 is a partial cross-sectional side view illustration of the distalend of a probe having an axial opening.

FIG. 5 is a diagrammatic perspective illustration of a flexible stenthaving an integrated punctal anchor and a distal aperture.

FIG. 6 is an enlarged cross-sectional side view illustration of a stenthaving a temporarily deformable integrated proximal anchor structure.

FIG. 7 illustrates the insertion of a hollow graduated irrigating probeinto the lacrimal drainage system to confirm a passageway to the noseand to measure the distance from punctum to nasal floor.

FIG. 8 illustrates the insertion of a side-by-side oriented combinedlacrimal probe and stent structure into the lacrimal drainage system.

FIG. 9 illustrates disconnecting the distal end of the stent from theprobe using the forced injection of fluid through the probe.

FIG. 10 illustrates withdrawing the probe while holding the stent inplace.

FIG. 11 illustrates an alternate embodiment of the stent releasablysecured through a distal radial opening in the probe.

FIG. 12 illustrates a coaxial stylet engaging the channel of the probeto cut the stent free.

FIG. 13 illustrates a coaxial rod engaging the channel of the probe topush off a channel-engaging stent.

FIG. 14 illustrates a probe having an axial opening and afriction-enhancing outer collar.

FIG. 15 illustrates a probe having an axial opening narrower than itsaxial channel.

FIG. 16A-16E illustrates various integrated punctal anchor structures atthe proximal extemity of the stent.

DESCRIPTION OF THE EXEMPLARY EMBODIMENTS

Referring now to the drawing, there is shown in FIG. 3 a thecross-sectional view of a stent insertion structure 15 for inserting aflexible stent 20 into a patient's lacrimal drainage system from one ofthe puncta into the nasal cavity. This structure combines an elongated,flexible stent 20 secured in a side-by-side configuration to asemi-rigid, elongated, hollow probe 30. The distal extremity 22 of thestent is releasably secured to the distal end 32 of the probe. The sizeof the combined structure is selected by the surgeon to allow it to beinserted into the lacrimal drainage system. As the structure is threadedfrom the punctum to the nasal cavity, the probe pulls the stent alongwith it. Once emplaced, the stent is detached from the probe and theprobe withdrawn. An anchoring structure 27 associated with the proximalextremity 23 of the stent snugly secures the stent to the punctum.

The components of the combined insertion structure 15, primarily thestent 20 and probe 30, are preferably shaped so that they minimize theradial dimensions of the structure and thereby minimize its invasivenessduring the insertion procedure. The combined structure is furtherselected so that the structure has the proper range of rigidity, columnstrength and resistance to lateral bending that allow it to be used inthe procedure described below. In general, it has a slight degree offlexibility resulting from the choice of material and its dimensions toallow it to navigate the bends and angles of the lacrimal system butalso has sufficient rigidity to be pushed through the lacrimal systemand most encountered stenoses or obstructions into the nasal cavity.This arrangement also allows the probe to bear the insertion forcesplaced on the combined structure. The preferred flexural rigidity of theentire combined structure will depend on the anatomy of the patient andis selected to provide the above functionality while allowing thesurgeon to manipulate the combined structure from the proximal sideonly. In other words, the surgeon can emplace the combined structure inabsence of any guidewire, and while manipulating only those parts of thestructure that remain exposed proximally from the punctum. The physicalcharacteristics of the individual components can be selected toaccommodate the above defined flexural rigidity requirements.

As shown in FIGS. 3 and 5-6, the stent 20 of this embodiment is formedfrom a length of flexible tubing made from a biocompatible material suchas silicone, polyethylene, or other material known to those skilled inthe art. The tubular stent has an oblong body 21 having a distalextremity 22 and a proximal extremity 23. The stent can be substantiallyhollow, defining a central lumen 24 extending from a distal aperture 26to a barrier 27 located near the proximal extremity. Alternately, thestent can be solid, in which case the distal aperture terminates in aninternal pit. Alternately, the channel can extend, and be in fluidcommunication with both the distal aperture and a proximal aperture 25.

In this embodiment the distal aperture 26 is shaped and dimensioned tosnugly fit over the distal end 32 of the probe 30, thereby securing thestent to the probe by friction fit and occluding a distal opening 38 ofthe probe leading to its internal channel 34. As will be describedbelow, this friction fit is overcomable so that the surgeon can releasethe stent from the probe in vivo.

The dimensions of the stent will depend on the anatomy of the patient.For many applications, the preferred stent has an outside diameter DSoof between about 0.50 mm and about 3.00 mm, and can typically be about0.70 mm, an internal diameter DSi of between about 0.10 mm and about2.50 mm, and can typically be about 0.37 mm, and a length of betweenabout 10 mm and about 100 mm, and can typically be about 75.0 mm.

The proximal extremity 23 of the stent 20 can be formed into anintegrated punctal anchor structure 28. The anchor is shaped anddimensioned to provide a snug fit to the patient's own anatomy near thepunctum. In the present embodiment the anchor structure 28 ischaracterized by a generally cylindrical stem 51 having a proximal endformed into the widened flange or collar 29. The opposite distal end ofthe stem connects to the stent body 21 at an angle α formed between theaxis Aa of the stem and the axis As of the stent body 21. This angle canbe between about 0 and about 135 degrees, and is more commonly near 0 ornear 90 degrees.

The stem 51 has axial length L of between about 0.2 and about 8.0 mm,and is typically between about 2.0 and about 2.5 mm for most adult humanpatients. The stem 51 has a resting outside diameter DAo which allows itto fit comfortably in the punctum and adjacent portion of thecanaliculus, this diameter will depend on the anatomy of the patient andis preferably between about 0.1 and about 3.0 mm, and is typicallybetween about 0.7 and about 1.0 mm for most adult human patients, theaverage diameter is ideally about 0.9 mm.

The flange 29 is intended to rest against the lid margin just externalto the punctum to keep the anchor from migrating internally. The flangehas a generally rounded circular, elliptical or oval shape as seenperpendicular to the stem axis Aa and is dimensioned large enough tokeep it from migrating into the punctal lumen, but small enough to avoidirritating the eye. The major dimension DFo of the flange 29 will dependon the anatomy of the patient and is preferably between about 0.020 mmand about 4.0 mm, and is typically between about 1.0 and about 3.0 mmfor most adult human patients, the average diameter is often ideallybetween about 1.75 mm and about 2.5 mm.

The elbow of the transition between the stem 51 and stent body 21 alsoprovides an outward migration resistant structure.

Additionally, the integrated punctal anchor structure 28 can be made tobe deformable, further facilitating emplacement. Specifically, thedeformable punctal anchor has a very small, closed-ended cylindricalbore 56 extending through the stem 51 from the stent's proximal aperture25. Although the bore is shown penetrating the anchor in line with thestem axis As, the bore could penetrate from other directions, forexample radially. The bore is used by a stretching tool to temporarilyand resiliently deform the anchor and facilitate insertion through thepunctum. The stretching tool can operate similarly to an inserter usedto insert SNUG PLUGS brand punctum plugs available from FCI. The toolhas a distal prong which engages the bore of the anchor, and fingerswhich grasp the collar of the anchor and stretch the anchor axially overthe prong. The anchor stem is selected to have a resiliently reducablediameter so that while it is stretched axially, its outside diameter DAois reduced. The anchor is then inserted using the tool into the punctumand released whereupon it springs back into its “at rest” shape.

Various alternate structures for the anchor are shown in FIGS. 16A-16Edescribed below.

As shown in FIG. 3, the oblong probe 30 is hollow having an internalaxial channel 34 extending from a distal end 32 to an open proximal end33 having a connector 35 such as luer-lock which allows it to beconnected to a source of pressurized fluid and provide a convenientgrasping point for the surgeon to facilitate manipulation. The distalend 32 of the probe is preferably blunted, having a closed roundedsurface which facilitates insertion into the distal aperture 26 of thestent, and discouraging accidental penetration of the probe through thestent wall near its distal extremity. The blunt end also avoids damageto the lacrimal tissues in the event the stent becomes inadvertentlydislodged. The bunted end also allows the probe to be used in theinitial confirmation and measuring procedure described below inreference to FIG. 7.

The distal end 32 of the probe 30 has at least one opening 38 to allowpressurized fluid in the channel 34 to exit and dislodge the stent 20.The opening can be one or more holes penetrating radially through theside wall of the probe near the distal end as shown in FIG. 3.

The probe 30 is shaped dimensioned and made from materials which allowit to be semirigid so that it imparts the necessary flexural rigidity tothe combined stent and probe structure. The probe can be made ofstainless steel, Nitinol or other similar material known in the art.Although the probe is made of a rigid or semi-rigid material, its lengthand the relative thinness of its wall render it somewhat flexible andeasily bendable.

The dimensions of the probe 30 will also depend on the anatomy of thepatient. For many applications, the preferred probe has an outsidediameter DPo of between about 0.014 inch and about 0.060 inch, andtypically between about 0.022 inch and about 0.028 inch, an internaldiameter DPi of between about 0.010 inch and about 0.046 inch, andtypically between about 0.011 inch and about 0.016 inch, and a length ofbetween about 1 and about 15 inches, typically about 4 inches. Thisresults in a wall thickness of between about 0.002 inch and about 0.020inch, and typically between about 0.006 inch and about 0.008 inch. Thoseskilled in the art will recognize that subtracting the inner diameterfrom the outer diameter results in 2 times the wall thickness.

It should be noted that the outer diameter of the probe 30 at the distalend 32 is selected to allow it to intimately and snugly engage thedistal aperture 26 of the stent 20 and therefore form a friction fitovercomable by forces applied in vivo when the surgeon desiresdetachment. Further, the diameter of the central channel of the probe isselected to accommodate the flow of pressurized fluid, and in someembodiments the passage of a rigidizing or disengagement rod and/or astylet.

Optionally, the probe may have a handle, or a flattened or otherwiseenlarged section (not shown) at or near its proximal end, as can befound in many surgical probes, which can be used to facilitate itshandling.

As shown in FIG. 4, an alternate embodiment of the probe 40 provides anaxial opening 46 to its internal channel 44 at the distal end 42. Itwill be understood that the distal extremity of the stent can be shapedand dimensioned to snugly fit into the axial opening 46 of the proberather than over it.

It is noted that use of a radial hole can allow fluid to exit even whenthe distal axial tip of the probe is closed (as shown in FIG. 3) or isopen (as shown in FIG. 4) but blocked by the nasal floor for example.

Referring now to FIGS. 7-10, an exemplary method for emplacing aflexible stent using the above-described structure will be described.

As shown in FIG. 7, in order to form or confirm the existence of apassageway through the lacrimal drainage system from a punctum 2 to thenasal cavity 13, an irrigating lacrimal surgical probe 61 is selectedand inserted into a punctum 2 and pushed though the nasolacrimal duct 8and into the nasal cavity 13 of a patient. The surgeon confirms that theirrigating probe has penetrated all obstructions 62 and reached thenasal cavity 13 by connecting a syringe 60 filled withfluorescein-stained fluid 63 to the proximal luer-lock connector 64 onthe irrigating probe 61. Fluid is then injected through the probe andout the distal hole 65. The hole punctures radially through thecylindrical wall of the irrigating probe near its distal end 66 so thatit remains essentially unblocked even if the distal end touches thenasal floor 11. Optionally, the probe 30 used in the combined stent andprobe structure described with reference to FIGS. 3 and 4 can be used,without the stent attached, to confirm the passageway. A probe havingtwo or more distal radial holes can easily discharge fluid when one ofthe holes is blocked.

The fluid can be suctioned out of the nasal cavity 13 with a softsuction or other suction catheter 67. If the fluorescein-stained fluidirrigates easily and a large volume is suctioned out of the nose, thisindicates that the probe has penetrated all obstructions and stenosesand entered the nasal cavity. Otherwise, it is likely that the probe hasnot adequately penetrated or has followed a false passage. In this case,the probe must either be pushed further down the nasolacrimal duct intothe nasal cavity, or the probe must be pulled proximally until its tipis in the lacrimal sac, reoriented and pushed down again through thenasolacrimal duct into the nasal cavity. The same irrigation andsuctioning procedures are repeated as describe above until properpenetration has been confirmed.

Once proper penetration has been confirmed the surgeon reads thegraduation markings 68 located on the outer surface of the probe 61 andidentifies which of the markings is closest to the punctal opening 2.The markings are located at a range of distances from said distal end 66of the probe corresponding to a common range of anatomical distancesbetween a punctum and the nasal floor 11. From this information thesurgeon is able to measure the distance from the punctum to the nasalcavity in this patient and make a selection of the proper given lengthof stent to be inserted. The irrigating probe is then removed. In thisway, the added complication of shortening an over-long stent can beavoided.

The surgeon selects a lacrimal surgical probe and an oblong flexiblestent having a given length. The distal extremity of the stent isreleasably secured to the distal end of the probe.

As shown in FIG. 8, the combined probe and stent structure 71, orientedin a side-by-side configuration, is inserted into the lacrimal drainagesystem in a manner similar to the irrigation probe discussed above. Inother words, the distal end of the probe 30, carrying the distalextremity of the stent 20, is pushed from a punctum 2 to the nasalcavity 13. In this way, both the distal end and distal extremitytraverse the lacrimal drainage system simultaneously.

Specifically, the distal end 72 of the combined structure is insertedhorizontally through the punctum 2, canaliculus, and into the lacrimalsac 7. The structure is then oriented vertically and pushed down thenasolacrimal duct 8 into the nasal cavity 13 out the duct opening 9 intothe nasal cavity until it hits the nasal floor 11 while the proximal endof the structure remains proximally external to the punctum. Further,this step of the procedure is accomplished by manipulation of theproximal portion of the structure outside the lacrimal drainage system.

The duct in the drawing is shown in an oversized state for clarity.Typically, the duct would closely conform to the combined stent/probestructure. In this example, the structure is inserted into the superiorpunctum and canaliculus, but would work similarly in the inferiorpunctum and canaliculus. Placement is accomplished with greaterconfidence having just completed the insertion of the irrigation probeduring the passageway confirmation step.

Once the surgeon observes that the proximal end 23 of the stent 20 is inthe punctum 2, with only the proximal flange 29 of the anchor structureremaining external to the punctum, he or she can be reasonably confidentthat the distal end 72 of the combined stent/probe structure has reachedthe nasal cavity 13.

At this point the surgeon has the option to pull slightly proximally onthe probe while holding the anchor structure in place with a finger orother instrument in order to raise the distal end a distance 75 off thenasal floor 11 so that the nasal floor does not interfere withdetachment of the stent from the probe 30. However, in most cases thisstep of raising the distal end is unnecessary.

As shown in FIG. 9, the surgeon now connects a source of pressurizedfluid to the probe 30. For example, a syringe 84 filled withfluorescein-stained fluid 85 is connected to the luer lock 35 at theproximal end of the probe. Pressurized fluid is injected through theinternal channel of the probe. The fluid pressure builds until itovercomes the friction fit of the distal extremity 22 of the stent 20thereby detaching it from the distal end 32 of the probe.

If a hollow dual open-ended tube is used for the stent 20, the surgeoncan block the proximal aperture 25 of the stent using a finger 89 orother implement to prevent outflow of pressurized fluid during thedetachment step. In many embodiments however, fluid will be preventedfrom flowing out the proximal end of the stent by built-in barriers inthe lumen of the stent, or the stent not having a lumen extending itsentire length.

Detachment of the distal extremity 22 of the stent 20 from the probe 30can be confirmed by detecting an amount of injected fluid in the noseusing a suction catheter 67. Further, in this way, the location of thedistal end 32 of the probe and thus the now released distal extremity ofthe stent can be reconfirmed without visualization in the nasal cavity13 and without contacting the distal end of the probe in the nasalcavity using another instrument.

Additional irrigation, suctioning, or delivery of medications can beperformed through the probe after the stent has been disconnected.

FIG. 10 shows that the probe 30 is withdrawn while leaving the stent 20in place. Specifically, the probe can be withdrawn out the punctum 2 byapplying a withdrawing force 90 on the proximal end 33 of the probewhile simultaneously applying a balancing, inserting force 91 on theproximal extremity 23 of the stent The surgeon can use a finger or otherimplement 92 to provide the balancing force. This causes the probe tomove proximally with respect to the substantially stationary stent sothat the stent remains in place with its distal end 22 in the nasalcavity 13.

While the probe is being withdrawn, further suction, irrigation, ordelivery of medication can be provided to the various parts of thelacrimal drainage system that the tip of the probe passes on its wayout.

It should be understood that the side-by-side configured combined stentand probe structure can be emplaced using a guide sleeve or other hollowtubular structure that has already been emplaced in the lacrimaldrainage system.

After the probe is completely removed, the anchor structure should be inits proper position where the proximal flange rests against the outerrim of the punctum. However, if removal of the probe has slightlydislodged the anchor structure, the surgeon can push the anchor backinto place. Alternately, where a separate punctal anchor structure apartfrom the stent is used, it can be inserted at this time.

Unlike prior devices and methods, placement of the stent can beaccomplished in absence of visualization and in absence of retrieval ofthe distal extremity of the stent in the nose. Further, placement isaccomplished in absence of any shortening of the distal end of thestent. In other words, the surgeon does not need to visualize or use anyadditional instruments in the nose, and does not need to cut the distalend to obtain the desired length.

It is important to note that the same, but shorter device can be used tostent one of the puncta, its canaliculus, the common canaliculus,lacrimal sac, and nasolacrimal duct depending on the intendedpost-operative length of the stent.

A further advantage of the instant device is that it can be reversiblyemplaced in the lacrimal drainage system. In other words, the stent canbe easily removed weeks or months later by grasping it with a forcepsand pulling it out of the punctum during a typical office visit.

The combined stent/probe structure can also be used to emplace a stentduring a dacryocystorhinostomy (“DCR”). In this case, the stent goesthrough one or both canaliculi and a prepared opening, directly into thenose. Stenting or intubation of the DCR passageway can be performedsimilarly to the previously described embodiments. Specifically, after apassageway is formed, the stent secured to the probe is pushed throughthe inferomedial wall of the lacrimal sac, lacrimal fossa, and lateralnasal wall into the nasal cavity. Emplacement is confirmed using theinjection of a tracer fluid through the probe after the stent isdisconnected, and further irrigation and/or suctioning may be conductedthrough the probe.

Referring now to FIGS. 11-12, there is shown an alternate embodiment ofthe side-by-side configured stent insertion structure 115 having aflexible stent 120 oriented in a side-by-side configuration to a hollow,semi-rigid lacrimal surgical probe 130. The distal extremity 122 of thestent is secured to the probe by being inserted through a small,undersized radial hole 138 formed through the probe sidewall near theprobe's rounded distal end 132. It should be noted that the distalextremity of the stent does not need to be open as in the previouslydescribed embodiment. The resiliency of the stent material is reliedupon to form a friction fit between the distal extremity of the stentand the distal end of the probe through the undersized hole.

In order to temporarily increase the flexural rigidity of the combinedprobe/stent structure 115 in this or other embodiments, a stiffening rod140 having a rounded distal terminus 141 can be selected to coaxiallyengage the channel 134 of the probe 130. Therefore, the outside diameterof the rod is slightly smaller than the diameter of the probe channel.It should be noted that the rod can be pushed to the distal end of theprobe, thereby contacting, and helping to hold in place, the distalextremity of the engaged stent 122 during insertion into the lacrimaldrainage system. This can be useful when a stronger friction fit betweenthe stent and probe is required or anticipated being needed.

Typically, the length of the rod is at least as long as the probe, andmore preferably between about 0 and about 25 centimeters longer than theprobe and can be made of stainless steel, Nitinol or other similarmaterial known in the art. In most applications it is convenient to havethe rod be about 10 centimeters longer than the probe. An optionalmanipulable flattened or otherwise enlarged section 142 at or near theproximal end of the rod, as can be found in many surgical probes, can beused to facilitate its handling. Use of the rod further allows for theuse of a probe having a thinner wall, which can be less than 90%, oftenless than 75%, and sometimes even less than 50% of the thicknessrequired when no rod is present. A thinner wall reduces material cost,and provides a less intrusive cross-section.

It should be understood that a stiffening rod can used in the embodimentof the probe of FIG. 4. However, care should be taken so that the distalterminus 141 of the rod does not penetrate so far as to dislodge thestent from the tip of the probe inadvertently. Such a rod can be used topurposefully dislodge the stent from the probe at the appropriate time.The rod can be marked on its outer surface to have an indicator showingwhere further penetration of the rod into the probe will cause the stentto dislodge. Optionally, the rod can be further adapted to have aremovable barrier such as a clamp 144 which prevents insertion beyond agiven distance until the barrier is removed.

The combined stent and probe structure 115 is inserted through thelacrimal drainage system in a manner similar to the previous exemplaryembodiment.

As shown in FIG. 12, once the combined structure is emplaced, thesurgeon first removes any rigidizing rod. Next, the surgeon disconnectsthe stent 120 from the probe 130 by inserting a stylet 150 through thechannel 134 of the probe to cut away the distal portion 129 of the stentextending into the channel of the probe, thereby allowing the remainingstent to separate from the probe. Care should be taken to properlyorient the stylet within the probe or otherwise shape its cutting tip151 so that the stent is cut close to the hole.

As shown in FIG. 13, the combined stent/probe structure 152 can use aprobe 153 having a rounded distal end 154 and an internal channel 155which has a distal bend 156 in communication with a distal radial hole157. In this way, pressurized fluid or a rod 158 can be used to dislodgea solid stent 159 having its distal extremity engaging the opening (asshown), or to dislodge a hollow tubular stent secured in the fashion ofFIG. 3. If a rod is used, care should be taken to make the bend gradualenough to allow flexion of the rod.

As shown in FIG. 14, the probe 160 can be adapted to have an optionalrounded collar 161 extending radially outwardly near the distal end 162of the probe in order to provide a stronger friction fit between anover-the-probe-end stent. Those skilled in the art will recognize theoptional use of other equivalent friction adjusting structures.

FIG. 15 shows an embodiment where the probe 165 has a rounded distal end166 having an axial opening 167 of a smaller diameter the diameter ofthe internal channel 168. In this embodiment a rigidizing rod 169 can beused without fear of accidentally dislodging an over-the-probe-end stentby over insertion of the rod. The stent can be dislodged using apressurized fluid.

Referring now to FIGS. 16A-16E, there are shown various alternateembodiments of the proximal extremity of the stent formed into a punctalanchor structure.

In FIG. 16A, the anchor structure 170 is characterized by a pair ofspaced-apart, diametrically widened flanges 171,172. The proximal flange171 is intended to rest against the outer rim of the punctum while theinner, distal flange 172 enlarges to rest against the internal interfacebetween the canaliculus and the punctum. It should be noted that bothflanges can be circular, elliptical or oval in shape. In the presentembodiment the flanges are semi-circular having a flattened edge 19which is substantially tangent to the substantially cylindrical outersurface of the body 173 of the stent. This allows for greater lateralmovement of the anchor structure with respect to the probe duringinsertion of the combined stent/probe structure. In other words, theanchor can be said to have a radial disuniformity which allows it tomore closely rest against a medial sidewall of said probe, therebyminimizing a lateral dimension of the combined probe/stent structure inits side-by-side configuration.

In FIG. 16B, the anchor structure 174 both flanges are shaped to includea substantially semicircular notch 175 for nesting against the outercylindrical wall of the probe. The notches allow the stent to nestintimately with the cylindrical outer surface of the body of the probein order to help minimize the diametric radial cross-sectional of thecombined stent/probe structure especially when the anchor structurepasses into the punctum along side the probe.

In FIG. 16C, the anchor stem 177 is oriented at an angle a to the body178 of the stent of about 90 degrees. In this case the more distalflange 179 forms a protuberance as an extension of the stent body beyondthe outer surface of the stem.

In FIG. 16D, the far edge 180 of the distal flange 181 is flattened asis the near edge to form a protuberance having width more closelymatching the diameter of the stent body 182.

In FIG. 16E the anchor stem 190 is extended a distance beyond thetransition to the orthogonally oriented stent body 191 to form aprotuberance 192. At rest, the protuberance is sized and shaped toengage the anatomy of the canaliculus to keep the anchor from extruding.

While the preferred embodiment of the invention has been described,modifications can be made and other embodiments may be devised withoutdeparting from the spirit of the invention and the scope of the appendedclaims.

1. A method for placing a stent in a patient's nasolacrimal duct whichcomprises the steps of: selecting an elongated semirigid tubular probeand an elongated flexible stent; wherein said probe has a proximal endand a distal end; wherein said stent has a proximal extremity and adistal extremity; wherein said distal extremity is detachably secured tosaid distal end; and, wherein said probe and said stent are oriented ina side-by-side configuration; pushing said distal end and said distalextremity through a patient's punctum, canaliculus, lacrimal sac,nasolacrimal duct and into the nasal cavity; detaching said distalextremity from said distal end while said distal end is located in saidcavity; proximally withdrawing said probe while leaving said distalextremity in said cavity; and, placing a punctal anchor associated withsaid proximal extremity within said patient's punctum.
 2. The method ofclaim 1, wherein method further comprises: said probe having an internalchannel, and a first opening to said channel near said proximal end; anda second opening to said channel near said distal end; and, wherein saidstent occludes said second opening of said channel.
 3. The method ofclaim 2, wherein said second opening comprises an axial hole extendingthrough an endwall of said probe to said channel.
 4. The method of claim2, wherein said second opening comprises at least one radial holeextending through a sidewall of said probe to said channel.
 5. Themethod of claim 1, wherein said selecting an elongated flexible stentfurther comprises: choosing said stent to be tubular; and, wherein saiddistal extremity is open, and shaped and dimensioned to snugly fit oversaid distal end of said probe.
 6. The method of claim 2, wherein saiddetaching comprises: injecting a fluid into said channel at a pressuresufficient to overcome a force detachably securing said distal extremityto said distal end.
 7. The method of claim 2, wherein said detachingcomprises: inserting a rod into said channel and contacting said distalextremity at a pressure sufficient to overcome a force detachablysecuring said distal extremity to said distal end.
 8. The method ofclaim 1, wherein said selecting comprises: determining a given lengthfor said stent, wherein said determining comprises measuring a distancefrom said punctum to said nasal cavity; wherein said measuringcomprises: inserting a graduated probe through said punctum to saidnasal cavity; confirming a distal end of said graduated probe is locatedin said nasal cavity, and, identifying a graduation mark on saidgraduated probe closest to the punctal opening.
 9. The method of claim2, which further comprises: stiffening said probe prior to said pushing;wherein said stiffening comprises: engaging said channel with an oblongrod having a first flexural rigidity which is more rigid than a secondflexural rigidity of said stent.
 10. The method of claim 1, wherein saidselecting of said probe comprises: choosing said probe to have at leastone radial hole near said distal end of said probe and wherein saiddistal extremity engages said hole.
 11. The method of claim 10, whereinsaid detaching comprises pushing a stylet into said channel to cut saidstent.
 12. The method of claim 1, wherein said method is practiced inabsence of retrieving a portion of said stent out the naris.
 13. Themethod of claim 1, wherein said method is practiced in absence ofvisualizing said stent within said nasal cavity.
 14. The method of claim1, wherein said method is practiced in absence of shortening said stentin vivo.
 15. The method of claim 1, wherein said placing a punctalanchor occurs during said pushing step.
 16. The method of claim 1,wherein said method further comprises: confirming that the distal end islocated in said nasal cavity; wherein said confirming comprises:injecting a tracing fluid through the probe; and recovering traces ofsaid fluid in said nasal cavity.
 17. The method of claim 1, whichfurther comprises injecting medication into said system through saidprobe.
 18. A method for stenting a passageway formed bydacryocystorhinostomy (“DCR”) which comprises the steps of: selecting anelongated tubular probe and an elongated flexible stent; wherein saidprobe has an open proximal end and an open distal end, and defines aninternal channel; and, wherein said stent has a proximal extremity and adistal extremity; and, wherein said distal extremity is detachablysecured to said distal end; pushing said probe carrying said stentthrough said passageway and into the nasal cavity; confirming that thedistal end of said probe is located in said nasal cavity; detaching saiddistal extemity from said distal end; proximally withdrawing said probewhile leaving said stent in place; and, placing a punctal anchorassociated with a proximal extremity of said stent within said patient'spunctum.
 19. A multi-functional surgical tool for the treatment ofnasolacrimal obstruction, stenosis or damage which comprises: a firstelongated semirigid tubular probe having proximal and distal ends; anelongated stent having proximal and distal extremities; wherein saiddistal extremity is releasably secured to said distal end; wherein saidprobe and said stent are oriented in a side-by-side configuration; apunctal anchor associated with said proximal extremity of said stent;and, wherein said anchor is sized and shaped to intimately andoversizedly engage said punctum.
 20. The tool of claim 19, wherein: saidprobe is shaped and dimensioned to define an internal channel; saidprobe has a first opening to said channel near said proximal end; and asecond opening to said channel near said distal end; and, wherein saidstent occludes said second opening of said channel.
 21. The tool ofclaim 20, wherein said second opening comprises an axial hole.
 22. Thetool of claim 20, wherein said second opening comprises a radial hole.23. The tool of claim 20, wherein said second opening comprises a pairof radial holes extending through a sidewall of said probe to saidchannel.
 24. The tool of claim 19, wherein said stent has a distalaperture shaped and dimensioned to snugly and releasably engaged by saiddistal end to form a friction fit.
 25. The tool of claim 19, whereinsaid probe has a distal opening shaped and dimensioned to snugly andreleasably engaged by said distal extremity to form a friction fit. 26.The tool of claim 19, which further comprises a first connector at aproximal end of said probe adapted to releasably connect to apressurized fluid source.
 27. The tool of claim 26, wherein said sourceemits an amount of fluid at a pressure sufficient to overcome a staticfriction bond between said stent and said probe.
 28. The tool of claim20, which further comprises a first rod diametrically sized to engagesaid channel of said probe.
 29. The tool of claim 28, wherein said roddimensioned to contact a portion of said stent occluding said secondopening.
 30. The tool of claim 29, wherein said rod has distal cuttingsurface oriented to cut said stent through axial movement of said rodwith respect to said probe.
 31. The tool of claim 19, wherein: saidprobe has a first length; said stent has a second length shorter thansaid first length; and, wherein said second length is between about 10millimeters and about 100 millimeters.
 32. The tool of claim 19, whereinsaid probe has a maximum cross-sectional dimension of between about0.014 inch and about 0.060 inch.
 33. The tool of claim 19, wherein saidprobe further comprises graduation marking on an outer surface portionlocated at a range of distances from said distal end corresponding to acommon range of anatomical distances between a punctum and a nasalfloor.
 34. The tool of claim 19, wherein: said probe has a firstflexural rigidity allowing it to be introduced into a patient'snasolacrimal duct through one of said patient's canaliculi by pushing onportions of said probe located proximal to said one of said patient'scanaliculi; and, said stent having a second flexural rigidity less rigidthan said first rigidity.
 35. The tool of claim 19, wherein said anchorhas radial disuniformity shaped and dimensioned to rest against a medialsidewall of said probe, thereby minimizing a lateral dimension of theprobe and stent oriented in said side-by-side configuration.
 36. Amulti-functional surgical tool for the treatment of nasolacrimalobstruction, stenosis or damage which comprises: a first elongatedsemirigid tubular probe having proximal and distal ends, and defining aninternal channel; said probe being sized and having a first flexuralrigidity to be introduced into a patient's nasolacrimal duct through oneof said patient's canaliculi by pushing on portions of said probelocated proximal to said one of said patient's canaliculi; an elongatedstent having proximal and distal extremities; said stent having a secondflexural rigidity; wherein said second rigidity is less rigid than saidfirst rigidity; means for detachably securing said distal extemity tosaid distal end; and, an anchor sized to intimately and oversizedlyengage said punctum.